Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J MacEwan

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|July 30, 2013
Emerging therapeutic aspects in oncologyDavid J Macewan
Cellular Signalling|March 19, 2002
TNF receptor subtype signalling: differences and cellular consequencesDavid J MacEwan
Neurochemical Research|November 7, 2007
Interactions between TNF and GnRHDavid J MacEwan
Blood|July 25, 2015
TWEAKing for a fight with GVHDDavid J MacEwan
British Journal of Pharmacology|February 28, 2002
TNF ligands and receptors--a matter of life and deathDavid J MacEwan
British Journal of Pharmacology|May 13, 2015
Epigenetics and pharmacologyBarbara Stefanska, David J MacEwan
Cancers|November 12, 2013
The role of nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cellsStuart A Rushworth, David J Macewan
Blood|January 19, 2008
HO-1 underlies resistance of AML cells to TNF-induced apoptosisStuart A Rushworth, David J MacEwan
Cellular Signalling|February 13, 2007
TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cellsZhigang Zhou, Michelle C Connell, David J MacEwan
British Journal of Pharmacology|February 11, 2022
Themed issue: 'New avenues in cancer prevention and treatment'Barbara Stefanska, Steven J Tucker, David J MacEwan
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|July 30, 2013
Emerging therapeutic aspects in oncologyDavid J Macewan
Cellular Signalling|March 19, 2002
TNF receptor subtype signalling: differences and cellular consequencesDavid J MacEwan
Neurochemical Research|November 7, 2007
Interactions between TNF and GnRHDavid J MacEwan
Blood|July 25, 2015
TWEAKing for a fight with GVHDDavid J MacEwan
British Journal of Pharmacology|February 28, 2002
TNF ligands and receptors--a matter of life and deathDavid J MacEwan
British Journal of Pharmacology|May 13, 2015
Epigenetics and pharmacologyBarbara Stefanska, David J MacEwan
Cancers|November 12, 2013
The role of nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cellsStuart A Rushworth, David J Macewan
Blood|January 19, 2008
HO-1 underlies resistance of AML cells to TNF-induced apoptosisStuart A Rushworth, David J MacEwan
Cellular Signalling|February 13, 2007
TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cellsZhigang Zhou, Michelle C Connell, David J MacEwan
British Journal of Pharmacology|February 11, 2022
Themed issue: 'New avenues in cancer prevention and treatment'Barbara Stefanska, Steven J Tucker, David J MacEwan
Pageof 6